AtaiBeckley (ATAI) Change in Account Payables (2020 - 2026)
AtaiBeckley's (ATAI) quarterly Change in Account Payables came in at $6.0 million in Q1 2026, up 16447.22% year-on-year from N/an in Q1 2025, and up 16447.22% quarter-over-quarter from $36000.0 in Q1 2025.
AtaiBeckley (ATAI) Change in Account Payables (2020 - 2026) Analysis & Trends
AtaiBeckley (ATAI) has 6 years of Change in Account Payables data on file, last reported at $1.8 million in Q3 2025.
- For the quarter ending Q3 2025, Change in Account Payables rose 71.9% year-over-year to $1.8 million; the trailing twelve-month figure through Sep 2025 stood at $442000.0 (up 163.41% YoY), and the FY2024 full-year result was -$1.9 million, down 187.56% from the prior year.
- Change in Account Payables climbed to $6.0 million in Q1 2026 per ATAI's latest filing, from $36000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $6.0 million in Q1 2026 and bottomed at $36000.0 in Q1 2025.
- A 5-year average of $110894.7 and a median of -$22000.0 in 2024 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables slumped 1138.72% in 2021 and jumped 3631.82% in 2025, its largest moves.
- Tracing ATAI's Change in Account Payables over 5 years: stood at $4.0 million in 2021, then plunged by 115.06% to -$598000.0 in 2022, then slumped by 60.2% to -$958000.0 in 2023, then tumbled by 122.65% to -$2.1 million in 2024, then surged by 182.61% to $1.8 million in 2025.
- Business Quant data shows ATAI's Change in Account Payables at $1.8 million in Q3 2025, $777000.0 in Q2 2025, and $36000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | 1.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.96 Mn |
| Mar 31, 2026 | 5.96 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Jun 30, 2025 | 777,000.00 |
| Jun 30, 2025 | 777,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | -2.13 Mn |
| Dec 31, 2024 | -2.13 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | -22,000.00 |
| Jun 30, 2024 | -22,000.00 |
| Mar 31, 2024 | -742,000.00 |
| Mar 31, 2024 | -742,000.00 |
| Dec 31, 2023 | -958,000.00 |
| Dec 31, 2023 | -958,000.00 |